Transfuse Convalesc Plasma in Periph Vein, Perc, New Tech 5

This code describes the administration of convalescent plasma, which is plasma collected from individuals who have recovered from an infection and contains antibodies against that pathogen. The plasma is infused into a peripheral vein using a percutaneous approach, meaning through the skin without an open incision. This specific code identifies the use of convalescent plasma as a new technology, categorized under Group 5.

This code is used when a patient receives convalescent plasma via a peripheral intravenous line for therapeutic purposes, typically to provide passive immunity or neutralize circulating pathogens. Common scenarios include the treatment of severe infections, especially those for which other effective therapies are limited, such as certain viral illnesses. It signifies the use of this specific type of plasma as a novel treatment modality.

• Ensure the documentation clearly specifies "convalescent plasma" and not just general plasma transfusion.
• Verify the route of administration is percutaneous into a peripheral vein; central venous access would require a different approach value.
• Confirm that the documentation supports the "New Technology Group 5" designation for convalescent plasma.